AnalystsLucas WardLucas Ward's Stock Forecasts
AnalystsLucas Ward
Analyst Ranking
Bottom 1%
#5336 out of 5340 analysts
Average Return
-48.85%
Win Rate
11%4 out of 38
Risk vs Reward
Poor
Good
Lucas Ward's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vivos Therapeutics IncVVOS | +40.00% | $3.05 | $4.27 | 2024-08-20 - 2025-08-19 | Buy |
Heartsciences IncHSCS | +24.66% | $2.94 | $3.67 | 2024-09-23 - 2025-09-22 | Buy |
Liqtech International IncLIQT | +17.72% | $1.58 | $1.86 | 2025-04-07 - 2026-04-06 | Buy |
Liqtech International IncLIQT | +13.79% | $1.74 | $1.98 | 2024-11-25 - 2025-11-24 | Buy |
Lucas Ward Analyst Color
Get additional color on Lucas Ward's coverage of popular stocks
Lucas Ward's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vivos Therapeutics IncVVOS | 7 | Buy | $3.10 | +663.55% | Maintains | 2 months ago |
Aclarion IncACON | 7 | Buy | $7.50 | +271.29% | Maintains | 2 months ago |
60 Degrees Pharmaceuticals IncSXTP | 6 | Buy | $3.70 | +196.00% | Maintains | 2 months ago |
Liqtech International IncLIQT | 8 | Buy | $4.40 | +537.68% | Maintains | 2 months ago |
Heartsciences IncHSCS | 5 | Buy | $8.00 | +284.62% | Maintains | 4 months ago |
Cyclo Therapeutics IncCYTH | 2 | Buy | $0.95 | N/A | Maintains | 2 years ago |
Vision Marine Technologies IncVMAR | 2 | Buy | $1,080,000.00 | N/A | Maintains | 2 years ago |
Shiftpixy IncPIXY | 1 | Buy | $2,160.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.